Investigator-Assessed Disease Progression in a Phase 2 Study of Paltusotine in Patients with Neuroendocrine Tumors and Carcinoid Syndrome

Endocrine Abstracts 2026

View at publisher
Authors: MD Amr Mohamed, Michael J. Demeure, Joseph Dillon, O'Connor, MD, MSc Juan Manuel, MD Shagufta Shaheen, MD, MPH Simron Singh,, Ana Oviedo, Lowell Brian Anthony, MD, PhD Rachel Riechelmann,, Łukasz Hajac, Mary Alice Maluccio, Juliana Lorenzoni Althoff
+11 more Mariano Dioca, MD, Thorvardur Halfdanarson,, MD Andrew E. Hendifar, Ana Rosa Pinto Quidute, Mariana Scandizzo, Denka Markova, Zhimin Xiao, MPH Zaineb Sharafali, MD Alan Krasner, Bin Zhang, Aman Chauhan
DOI: 10.1530/endoabs.116.c3
Cited by: 1

Fields of Study & Subjects

Neuroendocrine Tumor Research Advances Pituitary Gland Disorders and Treatments Thyroid Cancer Diagnosis and Treatment

Publication details

Journal / source
Endocrine Abstracts
Publisher
Bioscientifica
Publication date
4 March 2026